1
|
Gasteiger N, Norman G, Grainger R, Eost-Telling C, Jones D, Ali SM, van der Veer SN, Ford CR, Hall A, Law K, Byerly M, Davies A, Paripoorani D, Shi C, Dowding D. Reporting quality of published reviews of commercial and publicly available mobile health apps (mHealth app reviews): a scoping review protocol. BMJ Open 2024; 14:e083364. [PMID: 38964792 PMCID: PMC11227806 DOI: 10.1136/bmjopen-2023-083364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2023] [Accepted: 06/14/2024] [Indexed: 07/06/2024] Open
Abstract
INTRODUCTION Reviews of commercial and publicly available smartphone (mobile) health applications (mHealth app reviews) are being undertaken and published. However, there is variation in the conduct and reporting of mHealth app reviews, with no existing reporting guidelines. Building on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we aim to develop the Consensus for APP Review Reporting Items (CAPPRRI) guidance, to support the conduct and reporting of mHealth app reviews. This scoping review of published mHealth app reviews will explore their alignment, deviation, and modification to the PRISMA 2020 items for systematic reviews and identify a list of possible items to include in CAPPRRI. METHOD AND ANALYSIS We are following the Joanna Briggs Institute approach and Arksey and O'Malley's five-step process. Patient and public contributors, mHealth app review, digital health research and evidence synthesis experts, healthcare professionals and a specialist librarian gave feedback on the methods. We will search SCOPUS, CINAHL Plus, AMED, EMBASE, Medline, APA PsycINFO and the ACM Digital Library for articles reporting mHealth app reviews and use a two-step screening process to identify eligible articles. Information on whether the authors have reported, or how they have modified the PRISMA 2020 items in their reporting, will be extracted. Data extraction will also include the article characteristics, protocol and registration information, review question frameworks used, information about the search and screening process, how apps have been evaluated and evidence of stakeholder engagement. This will be analysed using a content synthesis approach and presented using descriptive statistics and summaries. This protocol is registered on OSF (https://osf.io/5ahjx). ETHICS AND DISSEMINATION Ethical approval is not required. The findings will be disseminated through peer-reviewed journal publications (shared on our project website and on the EQUATOR Network website where the CAPPRRI guidance has been registered as under development), conference presentations and blog and social media posts in lay language.
Collapse
Affiliation(s)
- Norina Gasteiger
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
| | - Gill Norman
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
- NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle, UK
| | - Rebecca Grainger
- Department of Medicine, University of Otago, Wellington, New Zealand
| | - Charlotte Eost-Telling
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
| | - Debra Jones
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
| | - Syed Mustafa Ali
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
- Centre for Health Informatics, Division of Informatics, Imaging & Data Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
| | - Sabine N van der Veer
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
- Centre for Health Informatics, Division of Informatics, Imaging & Data Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
| | - Claire R Ford
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
| | - Alex Hall
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
| | - Kate Law
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- The Christie Hospital NHS Trust, Manchester, UK
| | - Matthew Byerly
- The University of Kansas School of Medicine, Wichita, Kansas, USA
| | - Alan Davies
- Centre for Health Informatics, Division of Informatics, Imaging & Data Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
| | - Deborah Paripoorani
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
- EMERGING Research Team, Manchester Royal Infirmary, Manchester, UK
| | - Chunhu Shi
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
| | - Dawn Dowding
- Division of Nursing, Midwifery & Social Work, The University of Manchester, Manchester, UK
- NIHR Applied Research Collaboration Greater Manchester, Manchester, UK
| |
Collapse
|
2
|
Giebel GD, Speckemeier C, Schrader NF, Abels C, Plescher F, Hillerich V, Wiedemann D, Börchers K, Wasem J, Blase N, Neusser S. Quality assessment of mHealth apps: a scoping review. FRONTIERS IN HEALTH SERVICES 2024; 4:1372871. [PMID: 38751854 PMCID: PMC11094264 DOI: 10.3389/frhs.2024.1372871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Accepted: 04/16/2024] [Indexed: 05/18/2024]
Abstract
Introduction The number of mHealth apps has increased rapidly during recent years. Literature suggests a number of problems and barriers to the adoption of mHealth apps, including issues such as validity, usability, as well as data privacy and security. Continuous quality assessment and assurance systems might help to overcome these barriers. Aim of this scoping review was to collate literature on quality assessment tools and quality assurance systems for mHealth apps, compile the components of the tools, and derive overarching quality dimensions, which are potentially relevant for the continuous quality assessment of mHealth apps. Methods Literature searches were performed in Medline, EMBASE and PsycInfo. Articles in English or German language were included if they contained information on development, application, or validation of generic concepts of quality assessment or quality assurance of mHealth apps. Screening and extraction were carried out by two researchers independently. Identified quality criteria and aspects were extracted and clustered into quality dimensions. Results A total of 70 publications met inclusion criteria. Included publications contain information on five quality assurance systems and further 24 quality assessment tools for mHealth apps. Of these 29 systems/tools, 8 were developed for the assessment of mHealth apps for specific diseases, 16 for assessing mHealth apps for all fields of health and another five are not restricted to health apps. Identified quality criteria and aspects were extracted and grouped into a total of 14 quality dimensions, namely "information and transparency", "validity and (added) value", "(medical) safety", "interoperability and compatibility", "actuality", "engagement", "data privacy and data security", "usability and design", "technology", "organizational aspects", "social aspects", "legal aspects", "equity and equality", and "cost(-effectiveness)". Discussion This scoping review provides a broad overview of existing quality assessment and assurance systems. Many of the tools included cover only a few dimensions and aspects and therefore do not allow for a comprehensive quality assessment or quality assurance. Our findings can contribute to the development of continuous quality assessment and assurance systems for mHealth apps. Systematic Review Registration https://www.researchprotocols.org/2022/7/e36974/, International Registered Report Identifier, IRRID (DERR1-10.2196/36974).
Collapse
Affiliation(s)
- Godwin Denk Giebel
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Christian Speckemeier
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Nils Frederik Schrader
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Carina Abels
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Felix Plescher
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Vivienne Hillerich
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Desiree Wiedemann
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | | | - Jürgen Wasem
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Nikola Blase
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Silke Neusser
- Institute for Healthcare Management and Research, University of Duisburg-Essen, Essen, Germany
| |
Collapse
|
3
|
Forsyth F, Moons P. Digital healthcare consumption: lessons about online information. Eur J Cardiovasc Nurs 2024; 23:e21-e22. [PMID: 37610240 DOI: 10.1093/eurjcn/zvad079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 08/03/2023] [Accepted: 08/08/2023] [Indexed: 08/24/2023]
Affiliation(s)
- Faye Forsyth
- Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, East Forvie, Cambridge Biomedical Campus, Cambridge CB2 0SR, UK
| | - Philip Moons
- KU Leuven Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35 PB7001, 3000 Leuven, Belgium
- Institute of Health and Care Sciences, University of Gothenburg, Arvid Wallgrens backe 1, 413 46 Gothenburg, Sweden
- Department of Paediatrics and Child Health, University of Cape Town, Klipfontein Rd, Rondebosch, 7700 Cape Town, South Africa
| |
Collapse
|
4
|
Fuat A, Ako E, Hargroves D, Holden D, Caleyachetty A, Carter M, Harris J, Roberts C, Nzeakor N, Vardar B, Williams H. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey. JOURNAL OF MARKET ACCESS & HEALTH POLICY 2023; 11:2267327. [PMID: 37954532 PMCID: PMC10634268 DOI: 10.1080/20016689.2023.2267327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Accepted: 10/03/2023] [Indexed: 11/14/2023]
Abstract
Objective Direct oral anticoagulants (DOACs) are first-line therapy for stroke prevention for 1.4 million atrial fibrillation (AF) patients in the UK. However, the rates of DOAC dosing below evidence-based recommendations are estimated between 9% and 22%. This study explores specific patient and physician factors associated with prescribing inappropriate DOAC underdoses. Methods DOAC-prescribing physicians within the UK completed both a clinical vignette survey, which contained 12 hypothetical patient profiles designed to replicate DOAC prescribing scenarios, and a physician survey to capture sociodemographic, clinical experience, and prescriber-related beliefs and motivations related to DOAC prescribing. Eight patient factors based on a literature search and an expert consultation process were varied within the vignettes. Associations between the prescribers' dosing choices and patient factors were explored via multilevel logistic regression. The analysis is focused on the most frequently selected DOACs, apixaban and rivaroxaban, both of which have different dosing guidelines. Results In all, 336 prescribers (69% male; 233/336) completed the survey, mostly general physicians (GPs) (45%) or cardiology specialists (36%) with a mean of 17.9 years' experience. Most prescribers (73%; 244/336) inappropriately underdosed at least once; rates between GPs and specialists were nearly identical. Patient factors most strongly associated with apixaban inappropriate underdosing included a history of major bleeding and falls. For rivaroxaban, these were major bleeding and severe frailty. Only 32% (106/335) of prescribers reported DOAC dosing guidelines as the sole influence on their prescribing behaviour. Among prescribers who did not inappropriately underdose, greater prescribing confidence was aligned to increased perception of inappropriate underdose risk. Conclusions Overall, patient factors such as major bleeding and severe frailty were found to be associated with inappropriate underdosing of apixaban and rivaroxaban. Furthermore, prescribers who were more confident in DOAC prescribing, and were more worried about the risk of stroke, were significantly less likely to inappropriately underdose. These findings suggest that all prescribers, regardless of speciality, may benefit from education and training to raise awareness of the risks associated with inappropriate DOAC underdosing.
Collapse
Affiliation(s)
- Ahmet Fuat
- Carmel Medical Practice, Nunnery Lane, Darlington, UK
| | - Emmanuel Ako
- Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
| | - David Hargroves
- Stroke Medicine, East Kent Hospitals University NHS Foundation Trust, Canterbury, UK
| | | | | | | | | | | | | | | | - Helen Williams
- Department of Medicines Optimisation, South East London Integrated Care System, and UCL Partners, London, UK
| |
Collapse
|
5
|
Gasteiger N, Dowding D, Norman G, McGarrigle L, Eost-Telling C, Jones D, Vercell A, Ali SM, O'Connor S. Conducting a systematic review and evaluation of commercially available mobile applications (apps) on a health-related topic: the TECH approach and a step-by-step methodological guide. BMJ Open 2023; 13:e073283. [PMID: 37308269 PMCID: PMC10277147 DOI: 10.1136/bmjopen-2023-073283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Accepted: 05/25/2023] [Indexed: 06/14/2023] Open
Abstract
OBJECTIVES To provide an overview of the methodological considerations for conducting commercial smartphone health app reviews (mHealth reviews), with the aim of systematising the process and supporting high-quality evaluations of mHealth apps. DESIGN Synthesis of our research team's experiences of conducting and publishing various reviews of mHealth apps available on app stores and hand-searching the top medical informatics journals (eg, The Lancet Digital Health, npj Digital Medicine, Journal of Biomedical Informatics and the Journal of the American Medical Informatics Association) over the last five years (2018-2022) to identify other app reviews to contribute to the discussion of this method and supporting framework for developing a research (review) question and determining the eligibility criteria. RESULTS We present seven steps to support rigour in conducting reviews of health apps available on the app market: (1) writing a research question or aims, (2) conducting scoping searches and developing the protocol, (3) determining the eligibility criteria using the TECH framework, (4) conducting the final search and screening of health apps, (5) data extraction, (6) quality, functionality and other assessments and (7) analysis and synthesis of findings. We introduce the novel TECH approach to developing review questions and the eligibility criteria, which considers the Target user, Evaluation focus, Connectedness and the Health domain. Patient and public involvement and engagement opportunities are acknowledged, including co-developing the protocol and undertaking quality or usability assessments. CONCLUSION Commercial mHealth app reviews can provide important insights into the health app market, including the availability of apps and their quality and functionality. We have outlined seven key steps for conducting rigorous health app reviews in addition to the TECH acronym, which can support researchers in writing research questions and determining the eligibility criteria. Future work will include a collaborative effort to develop reporting guidelines and a quality appraisal tool to ensure transparency and quality in systematic app reviews.
Collapse
Affiliation(s)
- Norina Gasteiger
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
- Division of Informatics, Imaging and Data Sciences, The University of Manchester, Manchester, UK
| | - Dawn Dowding
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
| | - Gill Norman
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
| | - Lisa McGarrigle
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
- Manchester Academic Health Science Centre, Manchester, UK
| | - Charlotte Eost-Telling
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
| | - Debra Jones
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
| | - Amy Vercell
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
- The Christie NHS Foundation Trust, Manchester, UK
| | - Syed Mustafa Ali
- Division of Informatics, Imaging and Data Sciences, The University of Manchester, Manchester, UK
| | - Siobhan O'Connor
- Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
| |
Collapse
|
6
|
Factors influencing self-management behavior during the "Blanking Period" in patients with atrial fibrillation: A cross-sectional study based on the information-motivation-behavioral skills model. Heart Lung 2023; 58:62-68. [PMID: 36403555 DOI: 10.1016/j.hrtlng.2022.11.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Revised: 11/09/2022] [Accepted: 11/11/2022] [Indexed: 11/18/2022]
Abstract
BACKGROUND Atrial fibrillation (AF) is becoming increasingly common. Effective self-management during the "Blanking Period" is critical. The Information-Motivation-Behavioral skills (IMB) model can be used to study health behaviors in chronic disease patients, but it has not been studied in AF patients. OBJECTIVE The goal of this study was to explore the influencing factors and interaction pathways of self-management behavior in AF patients during the "Blanking Period" using the IMB model. METHODS From June to December 2021, a cross-sectional design was conducted. Patients with AF during the "Blanking Period" (N=220) were recruited. They filled out several quantitative questionnaires, including the Jessa Atrial Fibrillation Knowledge Questionnaire, the Confidence in Atrial Fibrillation Management Scale, the Perceived Social Support Scale, the All Aspects of Health Literacy Scale, and the Self-care Scale for Chronic Atrial Fibrillation Patients. Data were analyzed using correlation analysis, multiple regression analysis, and path analysis. RESULTS Total score of self-management behavior was (33.83 ± 10.66). AF knowledge (β = 0.252, P < 0.001), self-management confidence (β = 0.219, P < 0.001), social support (β = 0.291, P < 0.001), and health literacy (β = 0.262, P < 0.001) were all positively correlated with patients' self-management behavior, accounting for 66.50 percent of the total variance. CONCLUSIONS During the "Blanking Period", the IMB model can be used to predict the factors that influence self-management behavior in AF patients. By using IMB model, interventions targeting patient-specific influencing factors could improve self-management behavior and quality of life in AF patients.
Collapse
|
7
|
Hawryszko M, Sławiński G, Kozłowski D, Lewicka E. Apple Watch-guided diagnosis of AVNRT in a pregnant woman-A case report and literature review. Front Cardiovasc Med 2022; 9:985421. [PMID: 36419494 PMCID: PMC9676225 DOI: 10.3389/fcvm.2022.985421] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2022] [Accepted: 10/25/2022] [Indexed: 09/08/2024] Open
Abstract
Cardiac arrhythmias occurring during pregnancy pose a therapeutic problem as antiarrhythmic drugs can be potentially harmful to the fetus. A 35-years-old woman in the 20th week of pregnancy was admitted to the Department of Cardiology due to the first episode of arrhythmia in her life. During the event, the patient was wearing an Apple Watch Series 6, which records a 30-sec single-channel ECG. The recording showed narrow QRS complex tachycardia of 216 bpm, and short RP interval and atrioventricular nodal reentrant tachycardia (AVNRT) was recognized. Due to the mild nature of the arrhythmia, antiarrhythmic pharmacotherapy was not initiated. The use of mobile health (mHealth) devices such as wearables and health monitoring applications is now a valuable addition to routine cardiac diagnostics for patients of all ages and levels of cardiovascular risk.
Collapse
Affiliation(s)
| | - Grzegorz Sławiński
- Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Gdańsk, Poland
| | | | | |
Collapse
|
8
|
Gawałko M, Hermans AN, van der Velden RM, Betz K, Vm Verhaert D, Hillmann HA, Scherr D, Meier J, Sultan A, Steven D, Terentieva E, Pisters R, Hemels M, Voorhout L, Lodziński P, Krzowski B, Gupta D, Kozhuharov N, Pison L, Gruwez H, Desteghe L, Heidbuchel H, Evens S, Svennberg E, de Potter T, Vernooy K, Pluymaekers NA, Manninger M, Duncker D, Sohaib A, Linz D, Hendriks JM. Patient motivation and adherence to an on-demand app-based heart rate and rhythm monitoring for atrial fibrillation management: data from the TeleCheck-AF project. Eur J Cardiovasc Nurs 2022; 22:412-424. [PMID: 35932189 DOI: 10.1093/eurjcn/zvac061] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 06/23/2022] [Accepted: 06/24/2022] [Indexed: 11/12/2022]
Abstract
AIMS The aim of this TeleCheck-AF sub-analysis was to evaluate motivation and adherence to on-demand heart rate/rhythm monitoring app in patients with atrial fibrillation (AF). METHODS AND RESULTS Patients were instructed to perform 60 s app-based heart rate/rhythm recordings 3 times daily and in case of symptoms for 7 consecutive days prior to teleconsultation. Motivation was defined as number of days in which the expected number of measurements (≥3/day) were performed per number of days over the entire prescription period. Adherence was defined as number of performed measurements per number of expected measurements over the entire prescription period.Data from 990 consecutive patients with diagnosed AF [median age 64 (57-71) years, 39% female] from 10 centres were analyzed. Patients with both optimal motivation (100%) and adherence (≥100%) constituted 28% of the study population and had a lower percentage of recordings in sinus rhythm [90 (53-100%) vs. 100 (64-100%), P < 0.001] compared with others. Older age and absence of diabetes were predictors of both optimal motivation and adherence [odds ratio (OR) 1.02, 95% coincidence interval (95% CI): 1.01-1.04, P < 0.001 and OR: 0.49, 95% CI: 0.28-0.86, P = 0.013, respectively]. Patients with 100% motivation also had ≥100% adherence. Independent predictors for optimal adherence alone were older age (OR: 1.02, 95% CI: 1.00-1.04, P = 0.014), female sex (OR: 1.70, 95% CI: 1.29-2.23, P < 0.001), previous AF ablation (OR: 1.35, 95% CI: 1.03-1.07, P = 0.028). CONCLUSION In the TeleCheck-AF project, more than one-fourth of patients had optimal motivation and adherence to app-based heart rate/rhythm monitoring. Older age and absence of diabetes were predictors of optimal motivation/adherence.
Collapse
Affiliation(s)
- Monika Gawałko
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands.,Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, 45147 Essen, Germany.,1st Department of Cardiology, Medical University of Warsaw, 02-197 Warsaw, Poland
| | - Astrid Nl Hermans
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands
| | - Rachel Mj van der Velden
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands
| | - Konstanze Betz
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands
| | - Dominique Vm Verhaert
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands.,Department of Cardiology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
| | - Henrike Ak Hillmann
- Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, D-30625 Hannover, Germany
| | - Daniel Scherr
- Department of Cardiology, University Clinic of Medicine, Medical University of Graz, 8036 Graz, Austria
| | - Julia Meier
- Department of Cardiology, University Clinic of Medicine, Medical University of Graz, 8036 Graz, Austria
| | - Arian Sultan
- Department of Electrophysiology, University of Cologne, Heart Center, 50937 Cologne, Germany
| | - Daniel Steven
- Department of Electrophysiology, University of Cologne, Heart Center, 50937 Cologne, Germany
| | - Elena Terentieva
- Department of Electrophysiology, University of Cologne, Heart Center, 50937 Cologne, Germany
| | - Ron Pisters
- Department of Cardiology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands
| | - Martin Hemels
- Department of Cardiology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands
| | - Leonard Voorhout
- Department of Cardiology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands
| | - Piotr Lodziński
- 1st Department of Cardiology, Medical University of Warsaw, 02-197 Warsaw, Poland
| | - Bartosz Krzowski
- 1st Department of Cardiology, Medical University of Warsaw, 02-197 Warsaw, Poland
| | - Dhiraj Gupta
- Department of Cardiology, Liverpool Heart and Chest Hospital, L14 3PE Liverpool, United Kingdom
| | - Nikola Kozhuharov
- Department of Cardiology, Liverpool Heart and Chest Hospital, L14 3PE Liverpool, United Kingdom.,Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, 4031 Basel, Switzerland
| | - Laurent Pison
- Department of Cardiology, Hospital East-Limburg, 3600 Genk, Belgium
| | - Henri Gruwez
- Department of Cardiology, Hospital East-Limburg, 3600 Genk, Belgium.,Department of Cardiovascular Sciences, University Hospitals Leuven, 3000 Leuven, Belgium
| | - Lien Desteghe
- Cardiology Department, Antwerp University Hospital and Antwerp University, 2650 Antwerp, Belgium.,Faculty of Medicine and Life Sciences, Hasselt University and Jessa Hospital, 3500 Hasselt, Belgium
| | - Hein Heidbuchel
- Cardiology Department, Antwerp University Hospital and Antwerp University, 2650 Antwerp, Belgium
| | | | - Emma Svennberg
- Deptartment of Cardiology, Karolinska University Hospital, 171 77 Stockholm, Sweden
| | - Tom de Potter
- Cardiovascular Center, Onze Lieve Vrouwziekenhuis, 9300 Aalst, Belgium
| | - Kevin Vernooy
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands
| | - Nikki Aha Pluymaekers
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands
| | - Martin Manninger
- Department of Cardiology, University Clinic of Medicine, Medical University of Graz, 8036 Graz, Austria
| | - David Duncker
- Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, D-30625 Hannover, Germany
| | - Afzal Sohaib
- Barts Heart Center, St Bartholomew's Hospital, EC1A 7BE London, United Kingdom.,Department of Cardiology, King George Hospital, IG3 8YB Ilford, United Kingdom
| | - Dominik Linz
- Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Universiteitssingel 50, 6229 HX Maastricht, The Netherlands.,Department of Cardiology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.,Center for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, SA 5000 Adelaide, Australia.,Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
| | - Jeroen M Hendriks
- Center for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, SA 5000 Adelaide, Australia.,Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, SA 5042 Adelaide, Australia
| |
Collapse
|
9
|
Cruz-Ramos NA, Alor-Hernández G, Colombo-Mendoza LO, Sánchez-Cervantes JL, Rodríguez-Mazahua L, Guarneros-Nolasco LR. mHealth Apps for Self-Management of Cardiovascular Diseases: A Scoping Review. Healthcare (Basel) 2022; 10:322. [PMID: 35206936 PMCID: PMC8872534 DOI: 10.3390/healthcare10020322] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2021] [Revised: 01/29/2022] [Accepted: 02/07/2022] [Indexed: 11/17/2022] Open
Abstract
The use of mHealth apps for the self-management of cardiovascular diseases (CVDs) is an increasing trend in patient-centered care. In this research, we conduct a scoping review of mHealth apps for CVD self-management within the period 2014 to 2021. Our review revolves around six main aspects of the current status of mHealth apps for CVD self-management: main CVDs managed, main app functionalities, disease stages managed, common approaches used for data extraction, analysis, management, common wearables used for CVD detection, monitoring and/or identification, and major challenges to overcome and future work remarks. Our review is based on Arksey and O'Malley's methodological framework for conducting studies. Similarly, we adopted the PRISMA model for reporting systematic reviews and meta-analyses. Of the 442 works initially retrieved, the review comprised 38 primary studies. According to our results, the most common CVDs include arrhythmia (34%), heart failure (32%), and coronary heart disease (18%). Additionally, we found that the majority mHealth apps for CVD self-management can provide medical recommendations, medical appointments, reminders, and notifications for CVD monitoring. Main challenges in the use of mHealth apps for CVD self-management include overcoming patient reluctance to use the technology and achieving the interoperability of mHealth applications with other systems.
Collapse
Affiliation(s)
- Nancy Aracely Cruz-Ramos
- Tecnológico Nacional de México/I. T. Orizaba, Av. Oriente 9, No. 852, Col. Emiliano Zapata, Orizaba 94320, Mexico; (N.A.C.-R.); (L.R.-M.); (L.R.G.-N.)
| | - Giner Alor-Hernández
- Tecnológico Nacional de México/I. T. Orizaba, Av. Oriente 9, No. 852, Col. Emiliano Zapata, Orizaba 94320, Mexico; (N.A.C.-R.); (L.R.-M.); (L.R.G.-N.)
| | - Luis Omar Colombo-Mendoza
- Tecnológico Nacional de México/Instituto Tecnológico Superior de Teziutlán, Fracción l y ll, Teziutlán 73960, Mexico;
| | - José Luis Sánchez-Cervantes
- CONACYT-Tecnológico Nacional de México/I. T. Orizaba, Av. Oriente 9, No. 852, Col. Emiliano Zapata, Orizaba 94320, Mexico;
| | - Lisbeth Rodríguez-Mazahua
- Tecnológico Nacional de México/I. T. Orizaba, Av. Oriente 9, No. 852, Col. Emiliano Zapata, Orizaba 94320, Mexico; (N.A.C.-R.); (L.R.-M.); (L.R.G.-N.)
| | - Luis Rolando Guarneros-Nolasco
- Tecnológico Nacional de México/I. T. Orizaba, Av. Oriente 9, No. 852, Col. Emiliano Zapata, Orizaba 94320, Mexico; (N.A.C.-R.); (L.R.-M.); (L.R.G.-N.)
| |
Collapse
|
10
|
Hendriks JM, Spreeuwenberg MD, Linz D. Mobile health and cardiac arrhythmias: patient self-management in digital care pathways. Eur J Cardiovasc Nurs 2021; 20:631-632. [PMID: 34472602 DOI: 10.1093/eurjcn/zvab075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Accepted: 08/17/2021] [Indexed: 11/14/2022]
Affiliation(s)
- Jeroen M Hendriks
- Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Sturt Road, Bedford Park, Adelaide, SA 5042, Australia.,Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia
| | - Marieke D Spreeuwenberg
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Duboisdomein 30, Maastricht 6229 GT, The Netherlands
| | - Dominik Linz
- Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia.,Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, Maastricht 6229 HX, The Netherlands.,Department of Cardiology, Radboud University Medical Centre, Geert Grooteplein 28, Nijmegen 6525 GA, The Netherlands.,Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen 2200, Denmark
| |
Collapse
|
11
|
Jang I. A Systematic Review on Mobile Health Applications' Education Program for Patients Taking Oral Anticoagulants. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18178902. [PMID: 34501492 PMCID: PMC8430962 DOI: 10.3390/ijerph18178902] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 08/18/2021] [Accepted: 08/19/2021] [Indexed: 11/16/2022]
Abstract
Warfarin is widely used as an oral anticoagulant. However, it is difficult to manage patients due to its narrow therapeutic range and individualized differences. Using controlled trials and real-world observational studies, this systematic review aimed to analyze health education’s impact among patients on warfarin therapy by mobile application. Smartphone and tablet applications have the potential to actively educate patients by providing them with timely information through push notifications. MEDLINE, EMBASE, CINAHL, Web of Science, and Cochrane electronic databases were searched using the keywords “anticoagulants,” “warfarin”, “mobile application”, and “smartphone” up to May 2020. Of the 414 articles obtained, 12 articles met the inclusion criteria for this review. The education and self-management programs using the mobile health application had diverse contents. A meta-analysis was not deemed appropriate because of the heterogeneity of populations, interventions, and outcomes. Thus, a narrative synthesis is presented instead. This review demonstrates that educating patients for anticoagulation management through their smartphones or tablets improves their knowledge levels, medication or treatment adherence, satisfaction, and clinical outcomes. Moreover, it has a positive effect on continuing health care. Future research concerning patients taking warfarin should include key self-management outcomes in larger, more rigorously designed studies, allowing for comparisons across studies. This study proposes a continuous application of timely education through smartphone applications to the current medical and nursing practice.
Collapse
Affiliation(s)
- Insil Jang
- Department of Nursing, Chung-Ang University, Seoul 06974, Korea
| |
Collapse
|